Lista de obras -

A 24-week multicentre, randomized, open-label, parallel-group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatment

artículo científico publicado en 2019

A multidimensional assessment of the burden of psoriasis: Results from a multinational dermatologist and patient survey.

artículo científico publicado en 2018

A phase 4, randomised, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE)

scientific article published on 16 September 2020

An indirect comparison of long-term efficacy of every-2-week dosing vs. recommended dosing of ixekizumab in patients who had static Physician's Global Assessment > 1 at week 12

artículo científico publicado en 2019

Atopic dermatitis shows significant cutaneous comorbidity: results from large-scale investigations in the working population

scientific article published on 04 September 2019

Baseline characteristics of patients with moderate-to-severe psoriasis according to previous systemic treatment exposure: The PROSE study population

scientific article published on 02 April 2020

Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany

artículo científico publicado en 2019

Benefits of a membership in a psoriasis patient organisation: a quasi-experimental longitudinal study

artículo científico publicado en 2018

Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis

scientific article published on 02 June 2019

Continued treatment with secukinumab is associated with high retention or regain of response

artículo científico publicado en 2019

Correlation of psoriasis activity with socioeconomic status: cross-sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

scientific article published on 20 July 2018

Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany

artículo científico publicado en 2020

Cost-Effectiveness Analysis of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in Germany

scientific article published on 09 January 2020

Cost-of-illness of Melanoma in Europe - a systematic review of the published literature

artículo científico publicado en 2019

Cost-of-illness of melanoma in Europe - a modelling approach

scientific article published on 01 March 2019

Decreasing sunbed use in the German population between 2001-2015: survey in 155,679 working persons

article

Definition of psoriasis severity in routine clinical care: current guidelines fail to capture the complexity of long-term psoriasis management

artículo científico publicado en 2018

Determinants of costs and benefits in psoriasis routine care: Results from a cross-sectional nationwide study in Germany

artículo científico publicado en 2020

Development and psychometric evaluation of the U.S. English Wound-QoL questionnaire to assess health-related quality of life in people with chronic wounds

artículo científico publicado en 2020

Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy

artículo científico publicado en 2019

Disease burden and patient needs and benefits in anogenital psoriasis: developmental specificities for person-centred healthcare of emerging adults and adults

scientific article published on 12 November 2019

Does the Dermatology Life Quality Index (DLQI) underestimate the disease-specific burden of psoriasis patients?

artículo científico publicado en 2018

Economic evaluation of a tertiary prevention program for occupational skin diseases in Germany

artículo científico publicado en 2020

Education in people with venous leg ulcers based on a brochure about compression therapy: A quasi-randomised controlled trial

scientific article published on 16 August 2019

Effect of secukinumab on clinical activity and disease burden of nail psoriasis: 32-week results from the randomized placebo-controlled TRANSFIGURE trial

scientific article published on 16 January 2019

Effects of psychosocial interventions on patient-reported outcomes in patients with psoriasis: A systematic review and meta-analysis

artículo científico publicado en 2018

Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment

scientific article published on 17 September 2020

Epidemiology and dermatological comorbidity of seborrhoeic dermatitis: population-based study in 161 269 employees

scientific article published on 17 July 2019

Epidemiology of hidradenitis suppurativa in Germany - an observational cohort study based on a multisource approach

scientific article published on 08 October 2019

Factors Predicting Quality of Life Impairment in Adult Patients with Atopic Dermatitis: Results from a Patient Survey and Machine Learning Analysis

artículo científico publicado en 2023

Influence of human wound exudate on the bactericidal efficacy of antiseptic agents in quantitative suspension tests on the basis of European Standards (DIN EN 13727)

scientific article published on 05 March 2020

Linkage between patients' characteristics and prescribed systemic treatments for psoriasis: a semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registry

artículo científico publicado en 2019

Live interactive teledermatology compared to in-person care - a systematic review

scientific article published on 29 January 2020

Modelling first-year cost-of-illness of melanoma attributable to sunbed use in Europe

scientific article published on 01 March 2019

Nutritional status and quality of nutrition in chronic wound patients

scientific article published on 06 May 2020

Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population

scientific article published on 22 April 2020

Psychosocial Distress of Patients with Psoriasis: Protocol for an Assessment of Care Needs and the Development of a Supportive Intervention.

artículo científico publicado en 2018

Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non-Melanoma Skin Cancer

artículo científico publicado en 2019

Real-world evidence of secukinumab in psoriasis treatment - a meta-analysis of 43 studies

artículo científico publicado en 2020

Recurrent eczema herpeticum - a retrospective European multicenter study evaluating the clinical characteristics of eczema herpeticum cases in atopic dermatitis patients

artículo científico publicado en 2019

S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 1

scientific article published on 01 August 2019

S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 2

scientific article published on 01 September 2019

S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 1

artículo científico publicado en 2019

S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 2

artículo científico publicado en 2019

Secukinumab is effective in treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and safety from the PROSPECT study

artículo científico publicado en 2019

Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trial.

artículo científico publicado en 2017

Secukinumab treatment leads to normalisation of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: The PROSE study results

artículo científico publicado en 2020

Social participation of people with chronic wounds: A systematic review

artículo científico publicado en 2020

Strategies to reduce stigma related to visible chronic skin diseases: a systematic review

scientific article published on 05 August 2019

Sunbed use in Europe: Time for information

artículo científico publicado en 2019

The value of subcutaneous versus oral methotrexate - real-world data from the German psoriasis registry PsoBest

scientific article published on 21 November 2020

Time to revise the Dermatology Life Quality Index scoring in psoriasis treatment guidelines

artículo científico publicado en 2019

Topology of psoriasis in routine care: results from high-resolution analysis of 2009 patients

artículo científico publicado en 2019

Validation of a short-form of the Freiburg Life Quality Assessment for lymphoedema (FLQA-LS) instrument

artículo científico publicado en 2018

Lista de obras de

A 24-week multicentre, randomized, open-label, parallel-group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatment

A multidimensional assessment of the burden of psoriasis: Results from a multinational dermatologist and patient survey.

A phase 4, randomised, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE)

An indirect comparison of long-term efficacy of every-2-week dosing vs. recommended dosing of ixekizumab in patients who had static Physician's Global Assessment > 1 at week 12

Atopic dermatitis shows significant cutaneous comorbidity: results from large-scale investigations in the working population

Baseline characteristics of patients with moderate-to-severe psoriasis according to previous systemic treatment exposure: The PROSE study population

Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany

Benefits of a membership in a psoriasis patient organisation: a quasi-experimental longitudinal study

Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis

Continued treatment with secukinumab is associated with high retention or regain of response

Correlation of psoriasis activity with socioeconomic status: cross-sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany

Cost-Effectiveness Analysis of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in Germany

Cost-of-illness of Melanoma in Europe - a systematic review of the published literature

Cost-of-illness of melanoma in Europe - a modelling approach

Decreasing sunbed use in the German population between 2001-2015: survey in 155,679 working persons

Definition of psoriasis severity in routine clinical care: current guidelines fail to capture the complexity of long-term psoriasis management

Determinants of costs and benefits in psoriasis routine care: Results from a cross-sectional nationwide study in Germany

Development and psychometric evaluation of the U.S. English Wound-QoL questionnaire to assess health-related quality of life in people with chronic wounds

Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy

Disease burden and patient needs and benefits in anogenital psoriasis: developmental specificities for person-centred healthcare of emerging adults and adults

Does the Dermatology Life Quality Index (DLQI) underestimate the disease-specific burden of psoriasis patients?

Economic evaluation of a tertiary prevention program for occupational skin diseases in Germany

Education in people with venous leg ulcers based on a brochure about compression therapy: A quasi-randomised controlled trial

Effect of secukinumab on clinical activity and disease burden of nail psoriasis: 32-week results from the randomized placebo-controlled TRANSFIGURE trial

Effects of psychosocial interventions on patient-reported outcomes in patients with psoriasis: A systematic review and meta-analysis

Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment

Epidemiology and dermatological comorbidity of seborrhoeic dermatitis: population-based study in 161 269 employees

Epidemiology of hidradenitis suppurativa in Germany - an observational cohort study based on a multisource approach

Factors Predicting Quality of Life Impairment in Adult Patients with Atopic Dermatitis: Results from a Patient Survey and Machine Learning Analysis

Influence of human wound exudate on the bactericidal efficacy of antiseptic agents in quantitative suspension tests on the basis of European Standards (DIN EN 13727)

Linkage between patients' characteristics and prescribed systemic treatments for psoriasis: a semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registry

Live interactive teledermatology compared to in-person care - a systematic review

Modelling first-year cost-of-illness of melanoma attributable to sunbed use in Europe

Nutritional status and quality of nutrition in chronic wound patients

Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population

Psychosocial Distress of Patients with Psoriasis: Protocol for an Assessment of Care Needs and the Development of a Supportive Intervention.

Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non-Melanoma Skin Cancer

Real-world evidence of secukinumab in psoriasis treatment - a meta-analysis of 43 studies

Recurrent eczema herpeticum - a retrospective European multicenter study evaluating the clinical characteristics of eczema herpeticum cases in atopic dermatitis patients

S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 1

S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 2

S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 1

S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 2

Secukinumab is effective in treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and safety from the PROSPECT study

Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trial.

Secukinumab treatment leads to normalisation of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: The PROSE study results

Social participation of people with chronic wounds: A systematic review

Strategies to reduce stigma related to visible chronic skin diseases: a systematic review

Sunbed use in Europe: Time for information

The value of subcutaneous versus oral methotrexate - real-world data from the German psoriasis registry PsoBest

Time to revise the Dermatology Life Quality Index scoring in psoriasis treatment guidelines

Topology of psoriasis in routine care: results from high-resolution analysis of 2009 patients

Validation of a short-form of the Freiburg Life Quality Assessment for lymphoedema (FLQA-LS) instrument